Skip to content

Contingency Management for Smoking in Substance Abusers

Contingency Management for Smoking in Substance Abusers

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00683033
Acronym
R21
Enrollment
51
Registered
2008-05-23
Start date
2008-05-31
Completion date
2010-10-31
Last updated
2011-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Contingency Management, Cigarette Smoking Cessation, Substance Abusers

Brief summary

Patients (N=102) who meet diagnostic criteria for alcohol, cocaine, marijuana, or opiate abuse or dependence will meet with research staff on two days for quit preparation sessions (2 per day). These sessions include testing a breath sample for evidence of smoking twice each day (separated by at least 5 hours), counseling based on Public Health Service (PHS) guidelines for quitting smoking during the second session each day, and setting a quit date. After these sessions, participants will be randomly assigned to one of two 4-week conditions: (a) standard care or (b) standard care plus prize CM for smoking abstinence with the opportunity to win prizes for submitting samples that meet smoking abstinence criteria (e.g., CO ≤ 6ppm; cotinine ≤ 30ng/mL). Nicotine withdrawal and related measures will be assessed throughout the intervention. Follow-up data will be collected through 6-months post-quit date.

Interventions

BEHAVIORALContingency Management

For 4 weeks starting on the quit date, daily brief (about 5 minutes) counseling based on public health service guidelines for quitting smoking is delivered. Expired carbon monoxide (CO) tests are conducted twice daily and urinary cotinine tests are conducted once each week. Participants earn the opportunity to win prizes for submitting samples that meet smoking abstinence criteria (e.g., CO ≤ 6ppm; cotinine ≤ 30ng/mL).

For 4 weeks starting on the quit date, daily brief (about 5 minutes) counseling based on public health service guidelines for quitting smoking. Expired carbon monoxide tests are conducted twice daily and urinary cotinine tests are conducted once each week.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
UConn Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* current alcohol, cocaine, marijuana, or opiate abuse or dependence * smoke ≥ 10 cigarettes per day * expired CO \> 8 ppm * self-reported interest in quitting smoking, * ≥ 18 years old * willing to provide names, addresses and phone numbers of individuals to assist in locating the participant for follow-up evaluations, * English speaking

Exclusion criteria

* currently receiving behavioral therapy or pharmacotherapy for smoking plan to use pharmacotherapy in this quit attempt * serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, suicide risk) * cognitive impairment * in recovery for pathological gambling

Design outcomes

Primary

MeasureTime frame
Cigarette smoking abstinence.Daily through the 4-week intervention and at follow-up interviews 1, 2, 3, and 6 months following the quit date.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026